Robert J. Towarnicki

Chief Executive Officer at SIRPant Immunotherapeutics, Inc.

Health Technology

Commercial Services

Consumer Services

Profile

Robert J.
Towarnicki currently works at SIRPant Immunotherapeutics, Inc., as President, Chief Executive Officer & Director and Biotechnology Innovation Organization, as Member.
Mr. Towarnicki also formerly worked at Cell Pathways, Inc., as Chief Executive Officer, Nucleonics, Inc., as President & Chief Executive Officer from 2003 to 2009, Merck & Co., Inc., as Principal, Integra LifeSciences Holdings Corp., as Principal, Collagen Corp., as Vice President, Quest Diagnostics Infectious Disease, Inc., as General Manager, and Pfizer Pharmaceuticals, Inc., as Operations Manager.
Mr. Towarnicki received his undergraduate degree and graduate degree from Villanova University.

Robert J. Towarnicki active positions

Companies	Position	Start
Biotechnology Innovation Organization Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.	Corporate Officer/Principal	-
SIRPant Immunotherapeutics, Inc. SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki.	Chief Executive Officer	-

All active positions of Robert J. Towarnicki

Former positions of Robert J. Towarnicki

Companies	Position	End
Nucleonics, Inc. Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA.	President	2009-12-03
MERCK & CO., INC.	Corporate Officer/Principal	-
Pfizer Pharmaceuticals, Inc. Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.	Chief Operating Officer	-
Collagen Corp.	Corporate Officer/Principal	-
Quest Diagnostics Infectious Disease, Inc. Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA.	Corporate Officer/Principal	-

See the detail of Robert J. Towarnicki's experience

Training of Robert J. Towarnicki

Villanova University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert J. Towarnicki's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
INTEGRA LIFESCIENCES HOLDINGS CORPORATION	Health Technology
MERCK & CO., INC.	Health Technology

Private companies	7
Nucleonics, Inc. Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Nucleonics, Inc. develops RNA interference-based therapeutics. It offers DNA vaccine programs. The company was founded in January 2001 and is headquartered in Horsham, PA.	Health Technology
Cell Pathways, Inc. Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Cell Pathways, Inc. develops and commercializes drugs for the prevention and treatment of cancer	Health Technology
Quest Diagnostics Infectious Disease, Inc. Quest Diagnostics Infectious Disease, Inc. Miscellaneous Commercial ServicesCommercial Services Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA.	Commercial Services
Collagen Corp.	Health Technology
Pfizer Pharmaceuticals, Inc. Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.	Health Technology
Biotechnology Innovation Organization Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.	Commercial Services
SIRPant Immunotherapeutics, Inc. SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki.	Health Technology

See company connections